Moderna Says It Shipped About 800 Million Covid-19 Vaccine Doses in 2021
05 January 2022 - 1:15AM
Dow Jones News
By Will Feuer
Moderna Inc. said Tuesday that it shipped about 800 million
doses of its Covid-19 vaccine last year and said that bringing new
products to market are among its top priorities in the year
ahead.
The company also finished the year with cash, cash equivalents
and investments of more than $17 billion, Moderna Chief Executive
Stephane Bancel said in a letter to shareholders. He said the
company entered 2021 with a cash position of about $5.25
billion.
Bancel said the company continues to work on new products,
including a fall 2022 booster for its Covid-19 vaccine. Eventually,
the company hopes to combine the Covid-19 booster shot with a
booster for the flu vaccine. Moderna said it anticipates a
candidate for that combined shot to be in the clinic soon.
Developing such a pan-respiratory annual single-dose booster
vaccine, which would eventually also cover respiratory syncytial
virus, is Moderna's top priority in 2022, Bancel said.
The company's next priority is to develop vaccines against
latent viruses, such as HIV. It also hopes to develop therapeutics
using mRNA-encoded proteins, and said it will prioritize bringing
to market therapeutics based on mRNA-encoded gene editing
enzymes.
Moderna stock fell 1% in premarket trading Tuesday. Shares in
the company more than doubled in 2021, but are down almost 30% over
the past three months.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
January 04, 2022 09:00 ET (14:00 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Apr 2024 to May 2024
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From May 2023 to May 2024